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Within the past decade, two reports have appeared
purporting to demonstrate much greater human sensi-
tivities to the genetic effects of radiation than are
consistent with the Japanese or mouse data that I
summarized earlier in this program. This presentation
will review these reports, both of which are badly
flawed, and then proceed to a few poignant remarks
concerning the responsibilities of scientists, scientific
journals, and even the press, with respect to highly
sensitive genetic topics.
CHILDHOOD LEUKEMIA
IN WEST CUMBRIA, ENGLAND
In 1983, Yorkshire Television drew attention to an
apparent excess of childhood leukemia in the vicinity of
the Sellafield Nuclear Reprocessing Plant, which is
located in West Cumbria, England. The presentation
was sufficiently compelling that the English Govern-
ment commissioned a survey by an Independent Advi-
sory Group, which confirmed that there was indeed an
excess (Black, ’84; Gardner et al., ’87a,b), and Martin
Gardner and associates were then requested to under-
take a study of associated risk factors, with particular
reference to factors related to the plant. The subjects
were 52 persons with leukemia, 22 with non-Hodgkin’s
lymphoma, and 23 with Hodgkin’s disease, all with
onset in people born in the area between 1950 and 1983,
with diagnosis under the age of 25, and 1,001 controls
matched for sex and age taken from the same birth
registers as the cases (Gardner et al., ’90a,b). Associa-
tions were sought with such factors as place of resi-
dence, viral infections, child’s play habits, and parental
occupational histories. Some 80 possible associations
were investigated. (This number in itself immediately
raises the possibility of several ‘‘statistically signifi-
cant’’ false-positive associations simply on the basis of
the number of tests performed.) The principal positive
finding was that relative risks of leukemia and non-
Hodgkin’s lymphoma were higher in children born near
Sellafield and in children of father’s employed at the
plant. For example, the relative risk was 2.4 (95%
confidence interval [C.I.] of 1.0–5.7) for children of
fathers employed at Sellafield at the time of their
conception, and 6.4 (C.I. 1.67–26.3) for children of
fathers receiving a total preconceptual (external badge-
recorded) dose of ionizing radiation of more than 100-
mSv equivalents (but there were no exposures exceed-
ing approximately 200-mSv equivalents). The authors
focused special attention on the village of Seascale, 3
km south of Sellafield, where a clustering of cases had
been observed. Altogether seven cases had been diag-
nosed in residents of the village less than 25 years of
age in the 29 years 1955–1983, five of which were in
children less than 10 years of age, when less than one
case at these ages (actually, 0.5 cases) would have been
expected at national rates. Four of the fathers of the
affected children were employed in the Sellafield plant
(expectation, 0.6; relative risk, 6.4), where they had
received estimated total preconceptual (badge) doses of
ionizing radiation ranging from 97 to 188 mSv equiva-
lents over a period of 6–13 years. The authors con-
cluded that: ‘‘This result suggests an effect of ionizing
radiation on fathers that may be leukaemogenic in
their offspring, though other, less likely, explanations
are possible.’’ That they believe this effect was genetic is
indicated by their comparison of their findings with
other, avowedly genetic studies. The sensitivity of the
human genome to the genetic effects of ionizing radia-
tion implied by this interpretation is, of course, far, far
in excess of current estimates.
Understandably, the publication of these findings in
the British Medical Journal in February of 1990 elic-
ited a flurry of comments, some incredulous, some
hailing a new major insight into radiation effects. A
British law firm, Leigh, Day, and Company, advertised
its willingness to file claims against the organization
operating the facility, British Nuclear Fuel plc (BNFL),
and relatives of two of the children soon initiated action
against BNFL, claiming damage for personal injuries
and, in one of the two cases, death. A finding for the
Plaintiffs would challenge, worldwide, present permis-
sible occupational exposures to ionizing radiation, as
well as the validity of the major corpus of experimental
data from the mouse, and the observational data from
Japan on the children of atomic bomb survivors. Such a
finding would also trigger a flood of similar legal
actions. The stakes were high. So was the cost: The
London Times has estimated (October 15, 1992) that
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the resulting procedures, before the Royal High Courts
of Justice of England, are expected ‘‘to be a record
breaking legal action, costing up to £10 million.’’ (The
expenses of both plaintiffs and defendant will ulti-
mately be met by the government.)
Concerning the reliability of the findings of Gardner
and associates, there can be little doubt. A parallel
study by McKinney and associates (’91) on parental
occupations of children with leukemia in West Cum-
bria, North Humberside, and Gateshead, all areas in
which high rates of childhood leukemia had previously
been documented, confirmed the finding of the Gardner
group in West Cumbria, not surprising in view of the
overlap in subjects. But McKinney et al. (’91) also
reported significant associations of childhood leukemia
with the preconceptional exposure of fathers to wood
dust and benzene. The significance of these latter two
findings must be viewed in light of the fact that by the
authors’ estimate, 480 comparisons were made. It is
noteworthy that this study failed to confirm previously
reported associations of childhood leukemia with paren-
tal exposure to pesticides, plastics, and paint and
pigments—but these facts did not find their way into
the abstract of the McKinney paper, let alone inspire a
press release! Draper et al. (’93) several years later also
confirmed the excess of leukemia in the Seascale area,
and added additional data for 1984–1990, finding for
the latter period that ‘‘the incidence of malignant
disease, particularly lymphoid leukemia and non-
Hodgkin’s lymphomas in young people aged 0–24 in
Seascale was higher than would be expected.’’
The Legal Action Unfolds
The trial that resulted was conducted by a single
judge in the Royal High Courts of Justice in London.
During the course of the trial, there were approxi-
mately a dozen-plus expert witnesses on both sides, of
whom Jack Schull and I were two. What I think
impressed both of us were the academic-type witnesses
for the plaintiffs who either said, ‘‘we know so little
about radiation effects that the Sellafield findings could
indeed be a radiation effect,’’ or who sought to discredit
the Japanese study for various, sometimes arcane
reasons, none of which, fortunately, seem to have
impressed the judge.
At the end of the day, the evidence that led to the
judge finding against the plaintiffs was of two types,
biological and epidemiological. What follows is a conden-
sation of a more extensive analysis presented else-
where (Neel, ’94; see also Doll et al., ’94; Little et al., ’95;
Tawn, ’95; Wakeford, ’95). The principal issues raised
by the study can be summarized under four headings:
1. At the phenomenological level, there was a flat
contradiction between the failure to detect an in-
crease in childhood leukemia in the extensive stud-
ies on malignancies in the children of a-bomb survi-
vors (Yoshimoto et al., ’90, ’91) and the observations
regarding leukemia in Sellafield.
2. Earlier in this Symposium, it was suggested that the
zygotic doubling dose for humans of acute ionizing
radiation was of the order of 2 Sv equivalents. We
have also suggested that for chronic radiation expo-
sures, such as were experienced in the Sellafield
plant, the doubling dose could to a first approxima-
tion be set at 4-Sv equivalents (Neel et al., ’90). Let
us assume that childhood leukemia is the result of a
single dominant mutation (patently untrue; see
below). Then, assuming that a cumulative dose of
approximately 150 mSv to the Sellafield workers
resulted in a relative risk of 6.4 for leukemia in their
children, the doubling dose would become about 25
mSv, some 160 times lower than the estimate of the
doubling dose of chronic radiation developed earlier.
Little (’90), employing a somewhat different ap-
proach, places the discrepancy at 50- to 80-fold.
However, childhood leukemia is not based on a
single dominant mutation as is implied in that
comparison. It is not in a class with retinoblastoma,
neuroblastoma, or Wilms’ tumor, these the more
‘‘genetic’’ of the childhood malignancies. On the basis
of present evidence, not more than 5% of childhood
leukemia can be attributed to a genetic basis of the
type that accounts for familial retinoblastoma. This
is the fraction which should be responsive to a
radiation-induced mutation in the appropriate gene
in a parent. The fact that the Sellafield doses which
are reported are badge, not gonad, doses should
introduce another factor of ,1⁄2 into a comparison of
the Sellafield data. If we combine these various
considerations, the discrepancy between the results
of the Sellafield and Japanese studies is easily
several thousandfold.
3. Earlier in this Symposium, we briefly considered the
matter of the doubling dose for mice. If for the
moment you accept the zygotic doubling dose for the
acute radiation of mice of 2.7 Gy as the best cur-
rently available, adjust by a factor of 3 upward for
the fact that the radiation at Sellafield was chronic
in nature (cf. Russell, ’63), the discrepancy between
the mouse data and the genetic interpretation of the
Sellafield findings is even greater than with the
human data.
4. The Sellafield findings would require a remarkable
specificity for the genetic effects of radiation, which
effects are currently viewed as shotgun in nature.
Thus, if these findings were a genetic phenomenon,
there should have been a spectacular increase in the
frequency of other genetic disease resulting from
new mutations in the area covered by the Gardner
studies. However, Jones and Wheater (’89) reported
no increase in congenital defects in children born at
West Cumberland Hospital, which services the area
covered by the Gardner studies.
These, then, are the principal reasons for questioning
at the time of publication the validity of the conclusions
of Gardner and associates concerning the cause of the
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cluster of childhood leukemia in Seascale. However, as
time went along, a new set of epidemiological concerns
materialized. Not surprisingly, the Gardner report set
off a series of studies attempting confirmation. Three
independent studies of the association of childhood
leukemia with paternal employment in a nuclear instal-
lation failed to confirm the Gardner report (Kinlen, ’93;
Kinlen et al., ’93; McLaughlin et al., ’92; Roman et al.,
’93). Furthermore, the town of Seascale is only one of
several towns in the vicinity of the Sellafield plant in
which workers at the plant reside. A study of these
other areas yielded no evidence for an increase in
childhood leukemia correlated with paternal employ-
ment at the plant (Craft et al., ’93; Parker et al., ’93).
After some 8 months of intermittent testimony, the
judge deliberated for 4 months, and then issued such a
strong verdict in favor of the defendant, British Nuclear
Fuel, plc, that there has been no appeal. A verdict for
the plaintiff would, of course, have forced a reappraisal
of the radiation protection standards of all manner of
agencies, including this one. Before, however, you issue
a collective sigh of relief, I should tell you that a new
suit is brewing, involving attribution of a cluster of
children with Down’s syndrome in Ireland, in a locale
just across the Irish Sea from the Sellafield plant, to
maternal exposure to radioactive contamination from
the plant.
MINISATELLITE MUTATIONS IN BELARUS
Inasmuch as the genetic effects to be expected at the
levels of increased radiation to which human popula-
tions may be exposed are small, a proper genetic study
of the effects of a radiation exposure upon a population
demands impeccable controls. In such a situation, it is
tempting to look for a shortcut, some kind of easily
applied litmus paper test. That is exactly the trap into
which Dubrova and colleagues seem to have fallen in
their report in Nature (April 25, 1996). Studying germ-
line mutation rates in human minisatellite loci in the
Chernobyl fallout contaminated areas of the Mogilev
district of Belarus and in a control population, they
report that: ‘‘The frequency of mutation was found to be
twice as high in the exposed families as in the control
group.’’ Because both parents were exposed, this is a
zygotic rate. Minisatellites are regions of the DNA
characterized by a variable number of tandem repeats
of, usually, 5–45 bp identical units. They are relatively
common in the genome, and well known to exhibit a
high rate of spontaneous mutation, mutation in this
case consisting primarily in the gain or loss of one or
several of these repeat units. The mechanisms respon-
sible for these mutations are not well understood.
These mutations are not accompanied by any detect-
able phenotypic effect, i.e., appear to be of no conse-
quence to the person to whom they are transmitted.
This report, in a highly respected journal, can only
bring great and unwarranted distress to an already
badly stressed population. There are at least six rea-
sons why that report must be viewed with great cau-
tion:
1. Choice of controls: The control group of parents and
children were drawn from the United Kingdom. This
is a violation of one of the first principles of genetic
epidemiology, since these controls are neither
matched by environment nor by ethnicity. With
respect to the former, Belarus and surrounding
regions are known to be subject to a high level of
industrial pollution. With respect to the latter, strain
differences in mutation rates are very well known in
mice and Drosophila, and, especially for such labile
markers as minisatellites, certainly cannot be ex-
cluded for the human species.
2. Dosimetry: Dosage reconstruction for this area
presents many difficulties (Balonov, ’96). The princi-
pal source of radiation is 137Cs; the authors estimate
from various sources that the average individual
dose for external and internal chronic exposure to
this element was ‘‘less than 5 mSv per year.’’ Since
the children studied were born in 1994, both their
parents had been exposed to this dose for approxi-
mately 8 years, for a combined total maximum dose
of 8 3 2 3 5 5 80 mSv (or 8 rem) of chronic radiation,
and the average may be one-half of that! However,
what is important is the gonad dose, and this is
probably less than half the external dose. So, the
study is reporting an effect of gonadal doses of
radiation only a few rem above background.
3. Lack of perspective: Given the available estimates of
the doubling dose of chronic radiation for mice and
humans, their finding suggests sensitivities some
200 times greater than the literature. The authors
recognize the discrepancy and invoke the induction
by the radiation of some unknown intermediary
mechanism which then causes the mutation. Since
the basis for the gain or loss of repeat units which
they are measuring in these minisatellites is un-
clear, it is difficult to discuss this suggestion criti-
cally, but it is difficult to imagine a ‘‘special mecha-
nism’’ specific for this type of mutation that has not
previously come to light.
4. Treatment of results from Japan: At the time the
authors submitted their paper to Nature, they were
unaware of a comparable study at the RERF. This is
understandable, since the results of the study in
Japan were published in December 1995, and the
Nature paper appeared in April, 1996. The Japanese
study did, however, come to their attention in time to
add a note in proof, namely, ‘‘A similar study of
minisatellite mutation in a relatively small number
of families of atomic-bomb survivors from Hiro-
shima and Nagasaki has failed to show evidence for
mutation induction following acute exposure.’’ This
is a quite misleading statement. The average go-
nadal dose of the parents of the 64 Japanese chil-
dren who were studied was 1.9-Sv equivalents, so
that the total dose represented by these children
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was 64 3 1.9 5 121.6 Sv equivalents of acute
radiation. The exposure of the parents of the Belarus
children was ,7.5 years 3 5 mSv/year 3 2 par-
ents 3 79 children 5 5.9 Sv equivalents of chronic
radiation. Acute exposures to ionizing radiation, as
in Japan, are commonly held to be some two to three
times as effective in inducing mutation as chronic
exposures, as in Byelorussia. Therefore, the Japa-
nese study should have (121.6 3 3)/5.9 5 62 times
the power of the Byelorussian study. Mohrenweiser
(unpublished observations) in a preliminary study
also finds no effect of parental radiation on the rate
of minisatellite mutations, in studies of the children
of the so-called Chernobyl liquidators, for whom the
radiation dose was substantially higher than for the
parents reported by Dubrova et al. (’96). It is notewor-
thy that for both the Mohrenweiser study and that of
Kodaira et al. (’95), the data are counterhypothesis,
so that it is unlikely any expansion of either series
will produce a statistically significant effect of the
exposures.
5. Failure to discuss the discrepancy with the experi-
mental mouse data on the same subject: In support
of the validity of their finding, Dubrova et al. (’96)
cite two experiments demonstrating the production
of minisatellite mutations in mouse spermatogonia
by gamma radiation. In the first of these (Dubrova et
al., ’93), the gametic doubling dose was approxi-
mately 1.4 Gy, whereas in the second (Sadamoto et
al., ’94), the gametic doubling dose was approxi-
mately 3.8 Gy. The average is 2.6 Gy, the male
gametic rate, or, to a first approximation, a zygotic
rate of 5.2 Gy acute radiation, if we assume the same
response in the female. If we use the customary
factor of 3 in extrapolating from the effects of acute
to chronic radiation at the mouse exposure levels,
this estimate becomes 15.6 Gy. Thus, the human
data from Belarus suggest a sensitivity that is 195
times greater than the experimental results with
mice!
6. Choice of indicator: Finally, we must consider the
choice of the DNA indicator for this study. Certainly
a variety of types of DNA should be examined if
studies of the genetic effects of radiation move to the
DNA level. The choice of minisatellites was perhaps
dictated by their relatively high spontaneous rate,
and the thought that they might be an unusually
sensitive indicator of radiation effects. In my view,
however, we should not be concentrating on presum-
ably sensitive indicators, especially of unknown
function, but on a representative battery, of which
this might be only one.
In summary, there are many reasons to be skeptical
of the conclusions of Dubrova et al. (’96; see also
Léonard and Gerber, ’96). These authors, having raised
the issue, should be strongly encouraged to do a prop-
erly controlled study. Such a study, together with an
extension of the study of Kodaira et al. (’95) and of
Mohrenweiser (personal communication) should put
the matter to rest.
In closing, let us turn to the more general issue of
scientific responsibility. We live in an age of apprehen-
sion, and, indeed, there is much to be apprehensive
about as we attempt to look into the future. Stories
about genetic risks, playing on parental concerns for
their children, in particular create anxieties. It is,
therefore, essential and appropriate to conduct careful
and appropriate evaluations of each perceived threat as
it emerges, as well as continuing cost–benefit analyses
on established exposures, such as radiation. But those
conducting these evaluations carry heavy social respon-
sibilities. We have just considered two studies, one
certainly, and the other probably, unrepeatable. The
first sparked both widespread concern and a very
expensive chain of events, the other certainly contrib-
uted to the current great angst of those exposed to the
fallout from the Chernobyl disaster.
Elsewhere I have argued that by now the scientific
community should have acquired sufficient sophistica-
tion in epidemiological matters that when the results of
a study are at marked variance with a large body of
other data, the authors make it very clear how far out of
line their results are; that scientific journals that
sometimes seem as much in pursuit of hot items as the
tabloids, be more critical; and that science writers,
faced with an ‘‘astounding’’ development, exercise a
very high level of skepticism (Neel, ’94). It seems
strange that the journal Nature did not hold up publica-
tion of the paper by Dubrova et al. (’96), when, just
before publication, it learned of the negative study by
Kodaira et al. (’95). Whether bodies such as the NCRPM
have an expanded role to play in these situations is a
subject we might well discuss.
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